Thinking of taking your company public? Get our essential guide to a successful IPO. Download Now

Westicke Partners

Close

ICR Westwicke Blog

The ICR Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

What is an 8K and how do you read one?

Posted on June 25th, 2024. Posted by

what-is-an-8k-and-how-do-you-read-one

WHAT IS AN 8-K?

Form 8-K, also known as an 8K, is a form that is filed by public companies to notify their shareholders and the U.S. Securities and Exchange Commission (SEC) when an unscheduled material event takes place. In other words, it’s an announcement that a major event or corporate change that may be of interest to investors has occurred. Form 8K is known as a “current report” and is filed in addition to an annual report on Form 10-K and a quarterly report on Form 10-Q.

Continue Reading

Why Invest in Healthcare: 7 Trends to Watch

Posted on May 8th, 2024. Posted by

In the U.S., healthcare is a $4.3 trillion industry. But beyond its sheer size, there are a range of convincing reasons why the space is worthy of consideration by investors.

During the 2024 Benzinga Virtual Healthcare Summit, ICR Westwicke’s Mark Klausner, Co-Founder and Managing Partner, and Sameer Khambadkone, Partner and Head of Healthcare Capital Markets, discussed emerging trends in the healthcare sector and why investors should consider financing the exciting innovations in the industry.

Continue Reading

Is 2024 the Year for the Life Science IPO Market?

Posted on February 27th, 2024. Posted by

Woman,Laborant,Working,With,Microscope,Holding,Automatic,Pipette

Since November 2023, the IPO market for companies has shown some signs of life – dare we say, “green shoots.”  Over the most recent 15-week period, 10 firms transition to their new chapters as publicly listed companies. In 8 of the 10 cases, the stock price has risen above the new issue price, with notable increases from Cargo Therapeutics (“CRGX”) +55.0%; Arrivent Biopharma (“AVBP”) + 28.9%; and CG Oncology (“CGON”) + 129.5% (as of EOD, February 23). Continue Reading

Medical Technology in 2024 – Thoughts and Predictions for the Year Ahead

Posted on January 22nd, 2024. Posted by

Medical technology instrument used in hospital

With the J.P. Morgan Healthcare Conference behind us, now is the ideal time to opine on what the future holds for the MedTech sub-sector in 2024.

See below for several thoughts and key takeaways on the general sentiment and outlook for MedTech this year. This is my personal view, which has been informed in part by a review of outlook-focused, long-form research from nearly two dozen MedTech sell-side analysts, discussions with many of the top institutional investors in healthcare, and (seemingly countless) meetings with investors, analysts, bankers and clients during the week of the J.P. Morgan Conference. Continue Reading

AI in Healthcare: Gaining Momentum in 2024

Posted on January 15th, 2024. Posted by

medical records being viewed on a tablet

Artificial Intelligence (AI), instrumental in many healthcare trends of 2023, promises to dramatically gain momentum in 2024, with increased use of transformative technologies that have applications across the healthcare industry, from the way pharmaceuticals are developed and patients are treated to the commercial side of the business.

AI is already used in healthcare for end-to-end drug development, helping to diagnose patients, improving physician-to-patient communication, transcribing and organizing medical files and images, and treating patients remotely. Continue Reading

Going Public: Tell a Better Transaction Story

Posted on December 7th, 2023. Posted by

When entering the public markets, successfully announcing your milestone hinges on preparation and telling the right story at the right time. Learn how.

Continue Reading

10 Ways to Prep for the J.P. Morgan Healthcare Conference

Posted on November 16th, 2023. Posted by

Each year, the J.P. Morgan Healthcare Conference provides a critical opportunity to meet with analysts, investors, and other leaders in the healthcare industry. However, making the most of the conference takes preparation.

Continue Reading

The JPM Healthcare Media Maze: Crafting a Winning Approach

Posted on November 14th, 2023. Posted by

Pipette adding fluid to one of several test tubes

In less than two months, seasoned investors, influential media, game changing startups and established industry giants will convene at the 42nd Annual JP Morgan Healthcare Conference. Continue Reading

Top 10 Investor Relations Best Practices

Posted on September 29th, 2023. Posted by

Investor Relations

Properly positioning your story within the investment community can help you build a quality, long-term shareholder base and enhance equity market value. To develop an effective investor relations strategy, you must understand how to best interact with investors, stay visible, and adapt to deliver both good news and bad.

Continue Reading

Maintaining a “Future IPO” Mindset in Health and Life Sciences

Posted on July 31st, 2023. Posted by

Mature financial analyst telling company development strategy on presentation using computer technology

In 2019, I wrote a piece on Why You Need an IPO Communications Strategy Well Before the IPO.  That was before a pandemic, during which time the healthcare industry experienced a breakthrough year of SPACs and IPOs, only to be followed by an austere 18+ months of market uncertainty.  Add rising interest rates and a tough fundraising environment, and going public is now often a conversation that stays on the shelf.  But the outlook may be looking brighter and the life sciences industry is showing a heartbeat.

Continue Reading

1 2 3 30

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?

Our Locations